Experiments with implanted IL-1-releasing pellets into rat brains, leading to Tau-hyperphosphorylation, have suggested a function of IL-1 as trigger for the progression of neurofibrillary pathology in AD [39, 94]. The gene discussed is MAPT; the disease is Alzheimer disease.